DaVita HealthCare Partners Inc. (NYSE: DVA) (the "Company") today announced the pricing of $1.75 billion principal amount of 5.125% Senior Notes due 2024 (the "Senior Notes"). The offering is...
DaVita HealthCare Partners Inc. (NYSE: DVA) (the "Company") today announced that it intends to offer, subject to market and other conditions, $1.75 billion principal amount of senior notes due...
DaVita Rx, a full-service pharmacy created for patients with complex chronic conditions, such as those with kidney disease, announced today that it has filled its 15 millionth prescription since...
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced the release of its 2013 Community Care report, which...
DaVita HealthCare Partners Inc. (NYSE: DVA) (the "Company") today announced that it has commenced a tender offer to purchase for cash (the "Tender Offer") any and all of its 6 3/8% Senior Notes...